No Data
Some Investors May Be Worried About Jiangsu Libert's (SHSE:605167) Returns On Capital
Supervisor Huo Jiliang of Libet (605167.SH) completed a shareholding reduction, with a total decrease of 0.05 million shares.
Liebait (605167.SH) announced that the company's supervisor, Huo Jiliang, has cumulatively reduced his shareholding in the company through centralized bidding trade...
Investors Don't See Light At End Of Jiangsu Libert INC.'s (SHSE:605167) Tunnel
Third Quarter Report 2024
Libertec (605167.SH): The application for issuing convertible bonds has been accepted by the Shanghai Stock Exchange.
Gelonghui September 25th | Lipott (605167.SH) announced that on September 25, 2024, the company received a notice from the Shanghai Stock Exchange (hereinafter referred to as the 'Shanghai Exchange') 'Notice of Acceptance of the Application for the Issuance of Securities by Jiangsu Lipott Limited Company listed on the Shanghai Main Board' (Shanghai Stock Exchange [2024] No. 224), the Shanghai Exchange checked the prospectus and related application documents submitted by the company for the issuance of securities by the Main Board listed company in Shanghai in accordance with relevant regulations, considered that the application documents were complete and in compliance with statutory forms, decided to accept them and conduct a legal review.
Lepu Medical (605167.SH): has repurchased a total of 5.13 million shares
Gelonghui, September 3rd - Libote (605167.SH) announced that as of the end of August 2024, the company has cumulatively repurchased 5,130,000 shares, accounting for 1.14% of the company's total share capital. The highest purchase price was 7.979 yuan/share and the lowest purchase price was 6.110 yuan/share. The total amount paid was 34,809,291.00 yuan (excluding transaction fees).
